These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37695201)

  • 41. Nucleus-targeted delivery of nitric oxide in human mesenchymal stem cells enhances osteogenic differentiation.
    Cho DH; Hwang YJ; Park JH; Lee JY; Park JH; Jo I
    Bioorg Chem; 2023 Jun; 135():106483. PubMed ID: 37062230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
    Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
    Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.
    Zhang J; Qi H; Wang H; Hu P; Ou L; Guo S; Li J; Che Y; Yu Y; Kong D
    Artif Organs; 2006 Dec; 30(12):898-905. PubMed ID: 17181830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosome from indoleamine 2,3-dioxygenase-overexpressing bone marrow mesenchymal stem cells accelerates repair process of ischemia/reperfusion-induced acute kidney injury by regulating macrophages polarization.
    Xie X; Yang X; Wu J; Tang S; Yang L; Fei X; Wang M
    Stem Cell Res Ther; 2022 Jul; 13(1):367. PubMed ID: 35902956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive Tracking and Regenerative Capabilities of Transplanted Human Umbilical Cord-Derived Mesenchymal Stem Cells Labeled with I-III-IV Semiconducting Nanocrystals in Liver-Injured Living Mice.
    Chetty SS; Praneetha S; Govarthanan K; Verma RS; Vadivel Murugan A
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8763-8778. PubMed ID: 30741534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
    Nouri FS; Wang X; Hatefi A
    J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway.
    Chen L; Wang Y; Li S; Zuo B; Zhang X; Wang F; Sun D
    Theranostics; 2020; 10(20):9425-9442. PubMed ID: 32802201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery.
    Matsuzaka Y; Yashiro R
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury.
    Zhao L; Hu C; Han F; Wang J; Chen J
    J Cell Mol Med; 2020 May; 24(9):4882-4891. PubMed ID: 32281261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury.
    Cheng K; Rai P; Lan X; Plagov A; Malhotra A; Gupta S; Singhal PC
    Exp Cell Res; 2013 Aug; 319(14):2266-74. PubMed ID: 23806280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury.
    Li JK; Yang C; Su Y; Luo JC; Luo MH; Huang DL; Tu GW; Luo Z
    Front Immunol; 2021; 12():684496. PubMed ID: 34149726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. R-spondin signalling is essential for the maintenance and differentiation of mouse nephron progenitors.
    Vidal VP; Jian-Motamedi F; Rekima S; Gregoire EP; Szenker-Ravi E; Leushacke M; Reversade B; Chaboissier MC; Schedl A
    Elife; 2020 May; 9():. PubMed ID: 32324134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo.
    Salmasi Z; Hashemi M; Mahdipour E; Nourani H; Abnous K; Ramezani M
    Biotechnol Prog; 2020 Nov; 36(6):e3025. PubMed ID: 32410328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatiotemporal control of cell fate and cardiac differentiation.
    Davis ME
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5567-8. PubMed ID: 22255600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury.
    Cao J; Wang B; Tang T; Lv L; Ding Z; Li Z; Hu R; Wei Q; Shen A; Fu Y; Liu B
    Stem Cell Res Ther; 2020 May; 11(1):206. PubMed ID: 32460853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges.
    Chen F; Chen N; Xia C; Wang H; Shao L; Zhou C; Wang J
    Cell Transplant; 2023; 32():9636897231164251. PubMed ID: 37013255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth.
    Tu GXE; Ho YK; Ng ZX; Teo KJ; Yeo TT; Too HP
    Stem Cell Res Ther; 2020 Sep; 11(1):391. PubMed ID: 32917269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels.
    Hwang BW; Kim SJ; Park KM; Kim H; Yeom J; Yang JA; Jeong H; Jung H; Kim K; Sung YC; Hahn SK
    J Control Release; 2015 Dec; 220(Pt A):119-129. PubMed ID: 26485045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy.
    Gazit D; Turgeman G; Kelley P; Wang E; Jalenak M; Zilberman Y; Moutsatsos I
    J Gene Med; 1999; 1(2):121-33. PubMed ID: 10738576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.